Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
- 26 January 2016
- Vol. 59 (4), 198-219
- https://doi.org/10.1111/myc.12469
Abstract
The significant increase in the use of antifungal agents, both for the treatment of candidiasis and invasive aspergillosis and as azole fungicides in agricultural crop protection has resulted in the emergence of resistant clinical isolates, particularly to triazoles and echinocandins. Notably, among isolates that were primarily sensitive to fluconazole such as Candida parapsilosis and Candida tropicalis have witnessed an emerging resistance development. Also for echinocandins, the occurrence of Candida isolates with lower susceptibility to these drugs has been reported, which is possibly due to its broad clinical use. Triazole resistance among Aspergillus fumigatus and other Aspergillus species is commonly found in European and Asian countries. Specific mutations are associated with azole resistance in A. fumigatus and these mutations are now reported globally from six continents. Therefore, we highlight the need to conduct antifungal resistance surveillance studies using clinical isolates of Candida and Aspergillus in different geographical regions and monitoring of the infection rates in distinct population groups for early detection of resistance to these drugs and implementation of efficient policies for infection control and treatment.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (2012/04767-1)
- Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq), Brazil (308011/2010-4)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil (2012/04769-4, PNPD 23038.007393/2011-11)
This publication has 299 references indexed in Scilit:
- High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal DiseaseClinical Infectious Diseases, 2011
- A newly identified derivative of amphotericin B: isolation, structure determination and primary evaluation of the activity and toxicityThe Journal of Antibiotics, 2010
- Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literatureDiagnostic Microbiology and Infectious Disease, 2010
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010
- Fungal echinocandin resistanceFungal Genetics and Biology, 2009
- Functional analysis of Candida albicans GPI-anchored proteins: Roles in cell wall integrity and caspofungin sensitivityFungal Genetics and Biology, 2008
- New taxa of Neosartorya and Aspergillus in Aspergillus section FumigatiAntonie van Leeuwenhoek, 2007
- Resistance to echinocandin-class antifungal drugsDrug Resistance Updates, 2007
- The CCAAT-binding Complex of Eukaryotes: Evolution of a Second NLS in the HapB Subunit of the Filamentous Fungus Aspergillus nidulans Despite Functional Conservation at the Molecular Level between Yeast, A.nidulans and HumanJournal of Molecular Biology, 2005
- Evaluation of fluconazole resistance mechanisms in candida albicans clinical isolates from HIV-infected patients in BrazilDiagnostic Microbiology and Infectious Disease, 2004